University of Utah Orthopedic Center
Welcome,         Profile    Billing    Logout  
 18 Trials 
34 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Christensen, Thomas Broe
TOP-RCT, NCT05067153: Thromboprophylaxis in Oesophageal Cancer Patients

Recruiting
4
100
Europe
Fragmin 5000 UNT in 0.2 ML Prefilled Syringe, Low Molecular Weight Heparin
University of Aarhus, Aarhus University Hospital
Esophageal Neoplasms, Thrombosis, Thromboembolism
05/23
05/24
DOMINATOR, NCT05358158: Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection

Completed
N/A
94
Europe
Intraoperative air leak test, Intraoperative chest drain removal, Standard chest drain placement
Rigshospitalet, Denmark, Aarhus University Hospital
Lung Neoplasms, Lung Surgery, Enhanced Recovery After Surgery, Fast-track Surgery, Pain, Opioid Use, Remission
03/24
03/24
OLIGO-DK, NCT06356779: Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

Recruiting
N/A
1200
Europe
Local ablative therapy (LAT), Metastases-directed therapy
Gitte Fredberg Persson MD PhD
Oligometastatic Disease, Metastases, Ablation Techniques, Radiotherapy, Stereotactic Radiation, Surgery
12/30
12/35
FIVERVATS, NCT04095676: VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema

Recruiting
N/A
184
Europe
VATS group, Drain and intrapleural therapy group
Thomas Decker Christensen, Odense University Hospital, Rigshospitalet, Denmark, Aalborg University Hospital
Pleural Empyema
10/27
10/28
Phillips, John
NCT02624765: Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Completed
3
105
Europe, Canada, US, RoW
Digoxin (monotherapy), Sotalol (monotherapy), Flecainide (monotherapy), Digoxin (dual therapy), Sotalol (dual therapy), Flecainide (dual therapy)
Edgar Jaeggi, Canadian Institutes of Health Research (CIHR)
Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops, Fetal Supraventricular Tachycardia With Hydrops
03/24
03/24
SYNPHENY-3, NCT05764239: Efficacy and Safety of SYNB1934 in Patients With PKU

Terminated
3
35
Canada, US, RoW
SYNB1934v1, Placebo
Synlogic
Phenylketonuria
03/24
03/24
NCT03777982: Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Terminated
3
12
US
Prednisone, Deltasone, Apalutamide, ARN-509, Abiraterone Acetate, Zytiga, LHRH Agonist or Antagonist, GnRH
Dana-Farber Cancer Institute, Janssen Scientific Affairs, LLC
Prostate Cancer
02/24
02/24
PROPEL 2, NCT04265651 / 2019-002954-21: Study of Infigratinib in Children with Achondroplasia

Active, not recruiting
2
84
Europe, Canada, US, RoW
Infigratinib 0.016 mg/kg, Infigratinib 0.032 mg/kg, Infigratinib 0.064 mg/kg, Infigratinib 0.128 mg/kg, Infigratinib 0.25 mg/kg
QED Therapeutics, Inc.
Achondroplasia
10/24
12/24
NCT05145010 / 2021-001855-15: Extension Study of Infigratinib in Children with Achondroplasia (ACH)

Enrolling by invitation
2
300
Europe, Canada, US, RoW
Infigratinib
QED Therapeutics, Inc., QED Therapeutics, Inc.
Achondroplasia
12/31
02/32
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
NCT05222178: Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency

Terminated
1
3
US
HMI-103
Homology Medicines, Inc
Phenylketonurias, PAH Deficiency, Phenylketonuria
09/23
09/23
STAND, NCT04025008: A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee

Not yet recruiting
N/A
177
US
MicroStent or percutaneous transluminal angioplasty (PTA)
Micro Medical Solution, Inc.
Peripheral Arterial Disease
01/21
08/21
sCAVA, NCT04583826: - Sleep Assessment Using the CAVA Device

Suspended
N/A
40
Europe
CAVA
Norfolk and Norwich University Hospitals NHS Foundation Trust, University of East Anglia
Sleep
04/25
05/25
CAVA, NCT04026516: Dizziness Trial

Suspended
N/A
35
Europe
CAVA Device
Julie Dawson, University of East Anglia
Meniere's Disease, Benign Paroxysmal Positional Vertigo, Recurrent Vestibulopathy, Vestibular Migraine
05/25
05/25
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
NCT06238258: Dual Diagnosis Training Trial

Recruiting
N/A
55
US
SPECTROM Training
University of New Mexico
Training Group
01/26
01/26
NCT01561157: Longitudinal Study of the Porphyrias

Recruiting
N/A
1500
US
Icahn School of Medicine at Mount Sinai
Acute Porphyrias, Cutaneous Porphyrias
06/25
06/25
DEEPER REVEAL, NCT05358353: A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System for the TREatment of Vascular Lesions Located in the InfrapoplitEal Arteries BeLow the Knee

Active, not recruiting
N/A
130
US
Bare Temporary Spur Stent System
ReFlow Medical, Inc.
Peripheral Arterial Disease, Critical Limb Ischemia
05/24
05/25
CAVA 2, NCT05984901: The CAVA Multicentre Dizziness Trial

Recruiting
N/A
255
Europe
The continuous ambulatory vestibular assessment (CAVA) system
Norfolk and Norwich University Hospitals NHS Foundation Trust, University Hospitals, Leicester, St George's University Hospitals NHS Foundation Trust, Gloucestershire Hospitals NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Mid and South Essex NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust
Ménière's Disease, Vestibular Migraine, Benign Paroxysmal Positional Vertigo (BPPV)
10/24
03/25
NCT05409976: The GORE® VIAFORT Vascular Stent IVC Study

Active, not recruiting
N/A
111
Europe, US, RoW
GORE® VIAFORT Vascular Stent
W.L.Gore & Associates
Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis, Venous Ulcer, Venous Stenosis, Venous Occlusion, Vein Thrombosis, Vein Occlusion, Vein Disease
01/25
01/29
PROPEL, NCT04035811: Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Recruiting
N/A
250
Europe, Canada, US, RoW
QED Therapeutics, Inc.
Achondroplasia
06/26
06/26
Hutchinson, Douglas T
NCT05505513: Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?

Recruiting
N/A
3
US
percutaneous Utah Slanted Electrode Arrays (pUSEAs)
University of Utah
Amputation
12/25
12/25
Cushman, Daniel
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
PRP, NCT06184048: Validation of a Low-cost Platelet-Rich Plasma

Active, not recruiting
N/A
30
US
Intra-Articular knee injection of LC-PRP
University of Utah
Platelet-Rich Plasma (PRP), Knee Osteoarthritis (OA)
02/25
08/25
PRP for ALT, NCT06332352: Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears

Recruiting
N/A
30
US
PRP
University of Utah
Acetabular Labrum Tear
01/25
01/26
NCT06543368: Low-Cost Platelet-Rich Plasma for Hemarthropathy

Active, not recruiting
N/A
20
US
Intra articular PRP Injection
University of Utah
Hemarthrosis, Hemophilia
07/25
07/26
Petron, David
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Toth, Bob
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Monson, Nick
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Pierce, Jan
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Gee, Christopher
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Harold, Emily J
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
English, Joy
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25
Powell, Amy
NCT04886960: pAF for the Treatment of Osteoarthritis

Active, not recruiting
1/2
60
US
Amniotic Fluid Injection, Processed Amniotic Fluid, pAF, Human Amniotic Fluid, hAF, Standard of Care, Corticosteriods 3ml, one time dose
University of Utah
Osteo Arthritis Knee
01/25
01/25

Download Options